recursion logo on sign outside of brick building
Posted in General

After buying Cyclica and Valence, Recursion secures $50 million USD from Nvidia for drug discovery

Recursion, a US-based biotech firm, opened a new Canadian headquarters in Toronto last month. Computing giant Nvidia has invested $50 million USD in Recursion…

Continue Reading After buying Cyclica and Valence, Recursion secures $50 million USD from Nvidia for drug discovery
Odaia closes $34 million CAD Series B to fix “bottleneck” in drug delivery process
Posted in General

Odaia closes $34 million CAD Series B to fix “bottleneck” in drug delivery process

Roster of big pharma clients helped Odaia nab latest funding round. Toronto-based software startup Odaia has secured $34 million CAD ($25 million USD) in…

Continue Reading Odaia closes $34 million CAD Series B to fix “bottleneck” in drug delivery process
Drug discovery startup Congruence Therapeutics closes $20 million CAD extension of Series A
Posted in General

Drug discovery startup Congruence Therapeutics closes $20 million CAD extension of Series A

BDC Capital’s Thrive Venture Fund joined to lead the extension. Congruence Therapeutics has secured an additional $20 million CAD ($15 million USD) for its…

Continue Reading Drug discovery startup Congruence Therapeutics closes $20 million CAD extension of Series A
University of Alberta spinout DrugBank closes $9 million from Brightspark, Amplitude, Theodorus to fuel drug discovery with its data platform
Posted in General

University of Alberta spinout DrugBank closes $9 million from Brightspark, Amplitude, Theodorus to fuel drug discovery with its data platform

DrugBank wants to ‘be the shovel’ in a gold rush of new medical innovation. Training machine learning (ML) and artificial intelligence (AI) algorithms requires…

Continue Reading University of Alberta spinout DrugBank closes $9 million from Brightspark, Amplitude, Theodorus to fuel drug discovery with its data platform